Showing results (151-160 of 21,754) with videos related to
Sort By:
Pageof 2,176
British Journal of Cancer|June 17, 2010
Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal boneL Endo-Munoz, A Cumming, S Sommerville, et al.British Journal of Cancer|June 17, 2010
Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapyP Kelly, V Appleyard, K Murray, et al.British Journal of Cancer|June 17, 2010
Skin cancers associated with autoimmune conditions among elderly adultsE Lanoy, E A EngelsBritish Journal of Cancer|June 3, 2010
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trialS E Pinder, C Duggan, I O Ellis, et al.British Journal of Cancer|June 3, 2010
UHRF1 is a novel diagnostic marker of lung cancerM Unoki, Y Daigo, J Koinuma, et al.British Journal of Cancer|June 3, 2010
Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcomaM Eichenmüller, B Hemmerlein, D von Schweinitz, et al.British Journal of Cancer|December 16, 2010
Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancerF L Day, T Leong, S Ngan, et al.British Journal of Cancer|December 2, 2010
The role of FKBP5 in cancer aetiology and chemoresistanceL Li, Z Lou, L WangBritish Journal of Cancer|January 22, 2009
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)L Plowright, K J Harrington, H S Pandha, et al.British Journal of Cancer|January 22, 2009
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancersJ Ying, F F Poon, J Yu, et al.Pageof 2,176